The orthopaedic manifestation and outcomes of methicillin-sensitive Staphylococcus aureus septicaemia

The Bone & Joint Journal
D MakkiS Platt

Abstract

The aim of this paper was to present the clinical features of patients with musculoskeletal sources of methicillin-sensitive Staphylococcus aureus (MSSA) septicaemia. A total of 137 patients presented with MSSA septicaemia between 2012 and 2015. The primary source of infection was musculoskeletal in 48 patients (35%). Musculoskeletal infection was considered the primary source of septicaemia when endocarditis and other obvious sources were excluded. All patients with an arthroplasty at the time were evaluated for any prosthetic involvement. The most common site of infection was the spine, which occurred in 28 patients (58%), and was associated with abscess formation in 16. Back pain was the presenting symptom in these patients, with a positive predictive value of 100%. A total of 24 patients had a total of 42 arthroplasties of the hip or knee in situ. Prosthetic joint infection occurred in six of these patients (25%). In five patients, the infection originated outside the musculoskeletal system. Three patients (6%) with MSSA septicaemia from a musculoskeletal sources died. Amongst the musculoskeletal sources of MSSA septicaemia, the spine was the most commonly involved. We recommend an MRI scan of the whole spine and pelvis in ...Continue Reading

References

Feb 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D R MurdochG R Corey
Feb 5, 2002·Archives of Internal Medicine·Allan G JensenNiels Frimodt-Møller
Mar 21, 2002·Surgical Neurology·Jonathan A FriedmanMichael J Ebersold
May 25, 2004·Archives of Disease in Childhood·S LadhaniM C English
Apr 25, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christoph K Naber
Mar 5, 2011·The Lancet Infectious Diseases·Guy E ThwaitesUNKNOWN UK Clinical Infection Research Group
Jul 9, 2011·Case Reports in Neurology·Nicolas De SchryverPhilippe Hantson
Jan 5, 2012·International Orthopaedics·Juan Luis Cebrián ParraLuis Lopez-Duran Stern
Mar 14, 2012·The Journal of Infection·Seong Yeon ParkYang Soo Kim
Jun 3, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R B SaundersonM E Török
Aug 2, 2015·Current Environmental Health Reports·Tara C Smith, Shylo E Wardyn
Jun 22, 2016·European Journal of Orthopaedic Surgery & Traumatology : Orthopédie Traumatologie·Panagiotis KorovessisVasileios Syrimbeis

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.